AmerisourceBergen Corp. (NYSE:ABC) a Hold: Barclays

In a research note issued to investors, Eric Percher at Barclays Reiterated their Hold rating on AmerisourceBergen Corp. (NYSE:ABC). The analyst placed a $93.00 price target on the stock which indicates a 19.17% downside to the last closing price. In the year following Percher’s ratings, the stocks covered yield an average return of 10.6% according to TipRanks.com. In the past year 6 out of 7 recommendations or 86% were successful.

Wall Street sell-side analysts have placed a $112.333 one year price target on AmerisourceBergen Corporation (Holding Co) (NYSE:ABC). This is the consensus average based on 12 firms who have recently issued reports on the equity.

The average recommendation is the arithmetical average of the individual analyst ratings contributed by sell-side research to produce a Consensus Analyst Rating for each stock. On a scale of 1 to 5 where 1 represents a Strong Buy and 5 represents a Strong Sell,AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) is ranked 2 based on 12 broker recommendations. Of the 12 analyst estimates, the most bullish sees the stock reaching $130 within the next 12 months while the most bearish analyst sees the stock at $93 within the year.

Taking a look at the long term growth prospects of the stock, sell-side analysts have a consensus mean earnings per share estimate for the current year of $5.08. The high end estimate for this time frame is $5.33 with the low being $4.79.

According to analysts, AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) is expected to report earnings per share for the current fiscal quarter of $1.13. This is the consensus mean estimate based on the individual covering sell-side firm’s reported numbers. The company last reported earnings for the period ending on 2015-03-31 of $1.45.

AmerisourceBergen Corporation (AmerisourceBergenis) is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. In May 2013, the Company completed the divestiture of its contract packaging business, AndersonBrecon. In June 2013, the Company announced that has completed the divestiture of AmerisourceBergen Canada Corporation (ABCC).